Stem Cell Research
Novel neural cell model enables study of JC virus susceptibility
Published in Medical Letter on the CDC and FDA, June 29th, 2003
In a study from the United States, "multipotential human central nervous system progenitor cells, isolated from human fetal brain tissue by selective growth conditions, were cultured as undifferentiated, attached cell layers."
"Selective differentiation yielded highly purified populations of neurons or astrocytes," according to C.A. Messam and coauthors at the National Institute of Neurological Disorders and Stroke, who described "the novel use of this cell culture model to study cell type-specific recognition of a human neurotropic virus, JC virus," in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Clinical Trials
NCI and FDA announce joint program to streamline cancer drug development - Influenza Vaccine
Glycosylation has no impact on immunogenicity of DNA-based influenza vaccine - HIV/AIDS Prevention
Building evaluation capacity for HIV prevention programs outlined - HIV/AIDS Vaccine
Demand likely to outpace distribution of successful vaccine - Malaria
Anemia is maintained throughout parasitemia with Plasmodium vivax - Rheumatoid Arthritis Therapy
Infections caused by biologic treatments of rheumatoid arthritis - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
